Big Questions, Cool Drinks: A Psychedelics Science Night

⭐ Most nights out at a bar end in the same conversations. This one ends in understanding the science behind what psilocybin actually does to your brain, explained by someone who's read the clinical trials, all while your drink stays cold. A fun science night at the bar. Get your tickets now for Big Questions, Cool Drinks: A Psychedelics Science Night in London!

Highlights
🧠 Expert-led science talks on the neuroscience of psilocybin, MDMA
🔬 Info grounded on current peer-reviewed clinical research and published trial data (… no moralizing)
🙋 A fully open Q&A where no question is considered off-limits
🍺 A bar setting with a cold drink in hand - the opposite of a lecture hall
🔄 Different angles: clinical use, neuroscience, law & policy, microdosing, among others.

General Info
📅 Dates and times: select your date & time directly in the ticket selector
⏳ Duration: 45 minute lecture & 10 minute Q&A
📍 Location: 21Soho
👤 Age requirement: 18+
♿ Accessibility: Wheelchair accessible
❓ Please consult the FAQs of this experience here here

Description
The lights are low, your drink is cold, and someone who actually knows what they're talking about explains what psychedelics actually do inside your brain. Big Questions, Cool Drinks brings expert-led science talks into bar settings, and this edition is set to cover one of the most discussed topics in modern medicine. You'll hear what current clinical research shows about psilocybin as potential treatment for depression, MDMA and its benefits on PTSD. You will be informed and it will be done clearly: without slides, jargon, or judgment. The lecture runs 45 minutes, followed by 10 minutes of open questions where nothing is off the table. Just a knowledgeable speaker, a curious room, and cold drinks in hand. Get your tickets now for Big Questions, Cool Drinks: A Psychedelic Science Night in London!

Speaker Bio 
Dr. Ben Sessa is a consultant psychiatrist specializing in addictions and a leading pioneer in the field of psychedelic medicine. He graduated from University College London Medical School in 1997, and completed his postgraduate training in Child and Adolescent Psychiatry at Oxford University. Driven by a lifelong interest in pharmacology, psychotherapy, and trauma-based disorders, Dr. Sessa has spent decades at the forefront of psychedelic research. He conducted the world’s first clinical trial using MDMA-assisted therapy for alcohol use disorder and, in 2020, opened the UK’s first psychedelic medicine clinic in Bristol. He is a fully trained MDMA, psilocybin, and ketamine therapist, and is widely published across both academic journals and popular media on psychedelic and cannabis medicine.